Teratogenicity of sodium valproate
- 1 March 2005
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Safety
- Vol. 4 (2) , 345-353
- https://doi.org/10.1517/14740338.4.2.345
Abstract
The teratogenicity of the widely popular antiepileptic drug (AED) and mood stabiliser sodium valproate (also known as valproate, VPA) has been evidenced by previous research; however, these finding...Keywords
This publication has 66 references indexed in Scilit:
- Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosageJournal of Clinical Pharmacy & Therapeutics, 2004
- Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic dataBiopharmaceutics & Drug Disposition, 1999
- Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of actionPublished by Elsevier ,1999
- Pharmacokinetic Interactions Between Antiepileptic DrugsClinical Pharmacokinetics, 1996
- Pharmacokinetics of valproate in pregnancy: Mother-foetus-newbornInternational Journal of Clinical Pharmacy, 1992
- Nearly ubiquitous tissue distribution of the scrapie agent precursor proteinNeurology, 1992
- Valproate ToxicityDevelopmental Medicine and Child Neurology, 1988
- Drug Interactions with Valproic AcidDrugs, 1982
- Clinical Pharmacokinetics of Valproic Acid1Clinical Pharmacokinetics, 1980
- Transmission of valproic acid (Depakene) across theplacenta: Half-life of the drug in mother and babyThe Journal of Pediatrics, 1979